Reconstitution solution for Smallpox vaccine - RIVM
This tender concerns the production of a reconstitution solution for the Smallpox vaccine, specifically for use within the Rijksinstituut voor Volksgezondheid en Milieu (RIVM) under Good Manufacturing Practice (GMP). The tender is still open and contains insufficient details regarding price and duration. Notable information is recorded in the JSON object below.
Supplies · Open · European procedure
01What is being requested
This tender concerns the production of a reconstitution solution for the Smallpox vaccine, specifically for use within the Rijksinstituut voor Volksgezondheid en Milieu (RIVM) under Good Manufacturing Practice (GMP). The tender is still open and contains insufficient details regarding price and duration. Notable information is recorded in the JSON object below.
The assignment to produce Reconstitution solution for Smallpox vaccine for the RIVM under the GMP.
02Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
03Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.
04Likely competitors
05Legal themes that may be relevant here
06Frequently asked questions
What is the specific assignment of this tender?
Which quality standards must the production comply with?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 317K
€ 892K
€ 3,3 mln
Gegunde waarden in CPV 33 · leveringen n=528